MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
TSX:MDA - Toronto Stock Exchange - CA55293N1096 - Common Stock - Currency: CAD
Overall MDA gets a fundamental rating of 6 out of 10. We evaluated MDA against 11 industry peers in the Aerospace & Defense industry. While MDA has a great profitability rating, there are some minor concerns on its financial health. MDA is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make MDA a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
MDA had positive earnings in the past year.
In the past year MDA had a positive cash flow from operations.
Of the past 5 years MDA 4 years were profitable.
Each year in the past 5 years MDA had a positive operating cash flow.
1.2 Ratios
MDA has a Return On Assets of 3.46%. This is amongst the best in the industry. MDA outperforms 90.91% of its industry peers.
MDA has a better Return On Equity (8.11%) than 90.91% of its industry peers.
With a Return On Invested Capital value of 5.93%, MDA perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MDA is below the industry average of 8.10%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.93%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.46% | ||
| ROE | 8.11% | ||
| ROIC | 5.93% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
MDA has a better Profit Margin (8.06%) than 90.91% of its industry peers.
MDA's Profit Margin has improved in the last couple of years.
MDA has a Operating Margin (10.38%) which is comparable to the rest of the industry.
MDA's Operating Margin has improved in the last couple of years.
The Gross Margin of MDA (24.84%) is better than 72.73% of its industry peers.
In the last couple of years the Gross Margin of MDA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.38% | ||
| PM (TTM) | 8.06% | ||
| GM | 24.84% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
MDA has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MDA has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.10 indicates that MDA is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.10, MDA belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
MDA has a debt to FCF ratio of 0.17. This is a very positive value and a sign of high solvency as it would only need 0.17 years to pay back of all of its debts.
MDA's Debt to FCF ratio of 0.17 is amongst the best of the industry. MDA outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that MDA is not too dependend on debt financing.
MDA's Debt to Equity ratio of 0.10 is amongst the best of the industry. MDA outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.17 | ||
| Altman-Z | 2.1 |
ROIC/WACC0.65
WACC9.09%
2.3 Liquidity
A Current Ratio of 0.65 indicates that MDA may have some problems paying its short term obligations.
With a Current ratio value of 0.65, MDA is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
A Quick Ratio of 0.64 indicates that MDA may have some problems paying its short term obligations.
The Quick ratio of MDA (0.64) is better than 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.65 | ||
| Quick Ratio | 0.64 |
3. Growth
3.1 Past
MDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.50%, which is quite impressive.
Measured over the past years, MDA shows a very strong growth in Earnings Per Share. The EPS has been growing by 185.75% on average per year.
MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.98%.
MDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.32% yearly.
EPS 1Y (TTM)117.5%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%154.55%
Revenue 1Y (TTM)49.98%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%67.86%
3.2 Future
The Earnings Per Share is expected to grow by 34.73% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 23.41% on average over the next years. This is a very strong growth
EPS Next Y69.97%
EPS Next 2Y42.72%
EPS Next 3Y34.73%
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2Y29.89%
Revenue Next 3Y23.41%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 41.64, which means the current valuation is very expensive for MDA.
63.64% of the companies in the same industry are cheaper than MDA, based on the Price/Earnings ratio.
MDA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.28.
MDA is valuated quite expensively with a Price/Forward Earnings ratio of 25.41.
MDA's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of MDA to the average of the S&P500 Index (21.76), we can say MDA is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.64 | ||
| Fwd PE | 25.41 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDA indicates a slightly more expensive valuation: MDA is more expensive than 63.64% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDA indicates a rather cheap valuation: MDA is cheaper than 90.91% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.32 | ||
| EV/EBITDA | 19.09 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MDA may justify a higher PE ratio.
MDA's earnings are expected to grow with 34.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y42.72%
EPS Next 3Y34.73%
5. Dividend
5.1 Amount
MDA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (7/2/2025, 7:00:00 PM)
36.23
+1.12 (+3.19%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners30.22%
Inst Owner ChangeN/A
Ins Owners1.25%
Ins Owner ChangeN/A
Market Cap4.45B
Analysts78.18
Price Target35.55 (-1.88%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.62%
Min EPS beat(2)20.53%
Max EPS beat(2)28.71%
EPS beat(4)3
Avg EPS beat(4)24.14%
Min EPS beat(4)-9.44%
Max EPS beat(4)56.74%
EPS beat(8)7
Avg EPS beat(8)32.62%
EPS beat(12)10
Avg EPS beat(12)35.63%
EPS beat(16)13
Avg EPS beat(16)80.36%
Revenue beat(2)2
Avg Revenue beat(2)7.26%
Min Revenue beat(2)6.87%
Max Revenue beat(2)7.65%
Revenue beat(4)4
Avg Revenue beat(4)6%
Min Revenue beat(4)0.84%
Max Revenue beat(4)8.65%
Revenue beat(8)6
Avg Revenue beat(8)3.15%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)11
Avg Revenue beat(16)1.13%
PT rev (1m)-1.61%
PT rev (3m)0.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.6%
EPS NY rev (1m)0%
EPS NY rev (3m)1.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)16.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.64 | ||
| Fwd PE | 25.41 | ||
| P/S | 3.64 | ||
| P/FCF | 5.32 | ||
| P/OCF | 4.2 | ||
| P/B | 3.66 | ||
| P/tB | 23.67 | ||
| EV/EBITDA | 19.09 |
EPS(TTM)0.87
EY2.4%
EPS(NY)1.43
Fwd EY3.94%
FCF(TTM)6.81
FCFY18.8%
OCF(TTM)8.62
OCFY23.8%
SpS9.96
BVpS9.9
TBVpS1.53
PEG (NY)0.6
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.46% | ||
| ROE | 8.11% | ||
| ROCE | 8.23% | ||
| ROIC | 5.93% | ||
| ROICexc | 7.84% | ||
| ROICexgc | 65.94% | ||
| OM | 10.38% | ||
| PM (TTM) | 8.06% | ||
| GM | 24.84% | ||
| FCFM | 68.38% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexcg growth 3Y59.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.17 | ||
| Debt/EBITDA | 0.55 | ||
| Cap/Depr | 237.75% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 6.47 | ||
| Cash Conversion | 479.99% | ||
| Profit Quality | 848.33% | ||
| Current Ratio | 0.65 | ||
| Quick Ratio | 0.64 | ||
| Altman-Z | 2.1 |
F-Score6
WACC9.09%
ROIC/WACC0.65
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.5%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%154.55%
EPS Next Y69.97%
EPS Next 2Y42.72%
EPS Next 3Y34.73%
EPS Next 5YN/A
Revenue 1Y (TTM)49.98%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%67.86%
Revenue Next Year50%
Revenue Next 2Y29.89%
Revenue Next 3Y23.41%
Revenue Next 5YN/A
EBIT growth 1Y91.69%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year177.81%
EBIT Next 3Y52.71%
EBIT Next 5YN/A
FCF growth 1Y975.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1100.79%
OCF growth 3Y124.48%
OCF growth 5YN/A